Last updated at 04 Jul 2024 01:34 AM
Director
DIN: 08126437
Inder Chand Sharma is currently associated with 2 companies as Director. They serve as a Director at AAROGYAMSHAKTI PHARMACEUTICAL PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08126437.Inder Chand Sharma has previously been associated with 1 company in roles such as Additional Director.Inder Chand Sharma is currently involved in 1 different role. Their most recent position is with BAAZ DEVELOPERS PRIVATE LIMITED as a Director. The first company Inder Chand Sharma was appointed to as a director was AAROGYAMSHAKTI PHARMACEUTICAL PRIVATE LIMITED. Inder Chand Sharma is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Inder Chand Sharma is currently associated with 2 companies as Director. They serve as a Director at AAROGYAMSHAKTI PHARMACEUTICAL PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08126437.Inder Chand Sharma has previously been associated with 1 company in roles such as Additional Director.Inder Chand Sharma is currently involved in 1 different role. Their most recent position is with BAAZ DEVELOPERS PRIVATE LIMITED as a Director. The first company Inder Chand Sharma was appointed to as a director was AAROGYAMSHAKTI PHARMACEUTICAL PRIVATE LIMITED. Inder Chand Sharma is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
1y 6m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| AAROGYAMSHAKTI PHARMACEUTICAL PRIVATE LIMITED | Director | 10-May-2018 |
| BAAZ DEVELOPERS PRIVATE LIMITED | Director | 30-Sep-2023 |